COLLEGIUM PHARMACEUTICAL, INC (COLL) Operating Income (Loss) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Collegium Pharmaceutical, Inc quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
  • Collegium Pharmaceutical, Inc Operating Income (Loss) for the quarter ending March 31, 2024 was $49.5 M, a 101% increase year-over-year.
  • Collegium Pharmaceutical, Inc Operating Income (Loss) for the twelve months ending March 31, 2024 was $192 M, a 182% increase year-over-year.
  • Collegium Pharmaceutical, Inc annual Operating Income (Loss) for 2023 was $167 M, a 401% increase from 2022.
  • Collegium Pharmaceutical, Inc annual Operating Income (Loss) for 2022 was $33.3 M, a 89% increase from 2021.
  • Collegium Pharmaceutical, Inc annual Operating Income (Loss) for 2021 was $17.6 M, a 68.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $192 M $49.5 M +$24.8 M +101% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $167 M $61.7 M +$49.9 M +425% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $117 M $45 M +$24.5 M +120% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-22
Q2 2023 $92.5 M $35.6 M +$24.5 M +221% Apr 1, 2023 Jun 30, 2023 10-K 2024-02-22
Q1 2023 $68 M $24.6 M +$34.6 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $33.3 M $11.8 M +$45.9 M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$12.6 M $20.5 M +$6.32 M +44.7% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-22
Q2 2022 -$18.9 M $11.1 M -$5.3 M -32.3% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-22
Q1 2022 -$13.6 M -$10 M -$31.2 M -147% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-22
Q4 2021 $17.6 M -$34.1 M -$49.1 M -328% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $66.7 M $14.1 M -$5.48 M -27.9% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-23
Q2 2021 $72.2 M $16.4 M -$140 K -0.85% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-23
Q1 2021 $72.4 M $21.2 M +$16.1 M +319% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-23
Q4 2020 $56.2 M $15 M +$17.4 M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $38.9 M $19.6 M +$26 M Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 $12.9 M $16.5 M +$21.6 M Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 -$8.7 M $5.06 M +$15.1 M Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
Q4 2019 -$23.7 M -$2.37 M -$13.4 M -122% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$10.4 M -$6.38 M +$4.81 M +43% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$15.2 M -$5.01 M +$2.29 M +31.3% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$17.5 M -$9.99 M +$3.22 M +24.3% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$20.7 M $11 M +$28.6 M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$49.3 M -$11.2 M +$2.24 M +16.7% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 -$51.5 M -$7.29 M +$14 M +65.7% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 -$65.5 M -$13.2 M +$9.97 M +43% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 -$75.4 M -$17.6 M +$10 M +36.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$85.4 M -$13.4 M +$13 M +49.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$98.5 M -$21.3 M +$3.22 M +13.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$102 M -$23.2 M -$7.59 M -48.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$94.1 M -$27.6 M -$18.1 M -192% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$75.9 M -$26.4 M -$17.2 M -185% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-07
Q2 2016 -$58.8 M -$24.5 M -$19.9 M -435% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-07
Q1 2016 -$38.9 M -$15.6 M -$12 M -329% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-07
Q4 2015 -$26.9 M -$9.44 M -$6.11 M -184% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$20.8 M -$9.27 M -$2.76 M -42.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q2 2015 -$18 M -$4.58 M -$487 K -11.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-10
Q1 2015 -$17.6 M -$3.63 M +$114 K +3.04% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10
Q4 2014 -$17.7 M -$3.33 M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-18
Q3 2014 -$6.51 M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-18
Q2 2014 -$4.09 M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-18
Q1 2014 -$3.75 M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.